SCHEMBL3033563

SCHEMBL3033563

O=C(O)Cc1ccc([N+](=O)[O-])c(Oc2cccc3ccccc23)c1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.44
ALDH1A1 P00352 4/20 0.43
PIN1 Q13526 1/20 0.42
KDM4E B2RXH2 2/20 0.41
HPGD P15428 1/20 0.41
MAPT P10636 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
GAA P10253 2/20 0.41
PTGES O14684 2/20 0.40
HSPB1 P04792 1/20 0.40
ALOX5 P09917 2/20 0.40
MCL1 Q07820 1/20 0.40
CYP1A2 P05177 2/20 0.40
CXCL8 P10145 1/20 0.40
HTT P42858 2/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3038768 0.82 CYP1A2 (0.46) TDP1ALDH1A1HPGDMAPTMEN1
SCHEMBL3035330 0.81 ALDH1A1 (0.51) TDP1ALDH1A1PIN1KDM4EMAPT
SCHEMBL3027901 0.79 PIN1 (0.50) TDP1ALDH1A1PIN1KDM4EMAPT
SCHEMBL10422427 0.76 ALDH1A1 (0.68) TDP1ALDH1A1PIN1KDM4EHPGD
SCHEMBL19181626 0.76 CYP1A2 (0.49) ALDH1A1MEN1KMT2ACYP1A2SMN1; SMN2
SCHEMBL28151906 0.75 ALDH1A1 (0.48) TDP1ALDH1A1PIN1KDM4EHPGD
SCHEMBL3023944 0.74 PIN1 (0.40) ALDH1A1PIN1KDM4EMAPTMEN1
SCHEMBL16990735 0.73 CYP1A2 (0.55) TDP1ALDH1A1HPGDMAPTMEN1
SCHEMBL2515818 0.73 CYP1A2 (0.55) TDP1ALDH1A1HPGDMAPTMEN1
SCHEMBL3023941 0.73 PIN1 (0.41) ALDH1A1PIN1KDM4EMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 US disclosed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 US disclosed
EP-2166856-A1 CHEMICAL COMPOUNDS GlaxoSmithKline LLC (US) 2010-03-31 EP disclosed
WO-2008154271-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2008-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216746-A1 CHEMICAL COMPOUNDS SAMHD1, POLRMT, NUDT1 TDP1 243/4885ALDH1A1 348/4885PIN1 366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.